Ifp Advisors, Inc Alnylam Pharmaceuticals, Inc. Transaction History

Ifp Advisors, Inc

$2.42 Billion
Q2 2024

A detailed history of Ifp Advisors, Inc transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Ifp Advisors, Inc holds 49 shares of ALNY stock, worth $12,026. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 470 89.57%

Holding current value

$12,026

Previous $70,000 84.29%

% of portfolio

0.0%

Previous 0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$143.31 - $247.0 $60,333 - $103,987	-421 Reduced 89.57%	49 $11,000
Q1 2024 Jul 30, 2024	BUY	$146.51 - $198.2 $2,051 - $2,774	14 Added 3.07%	470 $70,000
Q4 2023 Jan 09, 2024	BUY	$151.41 - $196.57 $302 - $393	2 Added 0.44%	456 $87,000
Q3 2023 Oct 12, 2023	BUY	$170.77 - $211.65 $170 - $211	1 Added 0.22%	454 $80,000
Q2 2023 Aug 04, 2023	SELL	$185.01 - $212.05 $555 - $636	-3 Reduced 0.66%	453 $86,000
Q1 2023 Apr 18, 2023	SELL	$182.66 - $235.53 $37,079 - $47,812	-203 Reduced 30.8%	456 $91,000
Q4 2022 Feb 07, 2023	SELL	$185.53 - $241.31 $41,558 - $54,053	-224 Reduced 25.37%	659 $80,000
Q3 2022 Nov 08, 2022	BUY	$138.54 - $232.0 $19,811 - $33,176	143 Added 19.32%	883 $109,000
Q2 2022 Sep 06, 2022	BUY	$120.42 - $169.29 $89,110 - $125,274	740 New	740 $93,000
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $89,110 - $125,274	-740 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$127.18 - $173.91 $27,216 - $37,216	214 Added 40.68%	740 $120,000
Q1 2022 Aug 08, 2022	BUY	$127.18 - $173.91 $18,949 - $25,912	149 Added 39.52%	526 $85,000
Q4 2021 Jan 12, 2022	BUY	$159.56 - $209.29 $1,116 - $1,465	7 Added 1.89%	377 $73,000
Q3 2021 Oct 06, 2021	BUY	$169.75 - $207.73 $2,546 - $3,115	15 Added 4.23%	370 $77,000
Q2 2021 Jul 13, 2021	BUY	$128.63 - $176.89 $41,161 - $56,604	320 Added 914.29%	355 $60,000
Q1 2021 Apr 30, 2021	BUY	$126.83 - $175.69 $2,917 - $4,040	23 Added 191.67%	35 $5,000
Q4 2020 Jan 25, 2021	SELL	$122.97 - $147.0 $122 - $147	-1 Reduced 7.69%	12 $1,000
Q3 2020 Oct 29, 2020	BUY	$121.19 - $165.49 $484 - $661	4 Added 44.44%	13 $1,000
Q3 2019 Nov 07, 2019	BUY	$70.9 - $87.82 $638 - $790	9 New	9 $1,000
Q1 2019 May 15, 2019	SELL	$72.76 - $93.45 $14,552 - $18,690	-200 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$62.67 - $88.33 $22,623 - $31,887	-361 Reduced 64.35%	200 $14,000
Q3 2018 Oct 25, 2018	BUY	$87.52 - $122.67 $8,752 - $12,267	100 Added 21.69%	561 $0
Q2 2018 Aug 07, 2018	BUY	$88.31 - $107.8 $24,373 - $29,752	276 Added 149.19%	461 $0
Q1 2018 May 09, 2018	BUY	$115.92 - $148.54 $21,445 - $27,479	185 New	185 $0
Q4 2017 Jan 24, 2018	SELL	$114.49 - $139.98 $12,250 - $14,977	-107 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$72.53 - $118.27 $8,195 - $13,364	-113 Reduced 51.36%	107 $13,000
Q2 2016 Jun 03, 2019	BUY	N/A	220	220 $12,000

Others Institutions Holding ALNY

# of Institutions

643

Shares Held

109M

Call Options Held

1.28M

Put Options Held

1.21M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $30.2B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ifp Advisors, Inc with notifications on news.

Account